The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of ANAVEX2-73 in Patients With Rett Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03758924
Recruitment Status : Completed
First Posted : November 29, 2018
Last Update Posted : January 12, 2021
Sponsor:
Collaborator:
International Rett Syndrome Foundation Rettsyndrome.org
Information provided by (Responsible Party):
Anavex Life Sciences Corp.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : October 30, 2020
Actual Study Completion Date : October 30, 2020